Today: 27 April 2026

Lockheed Martin (LMT) Stock on December 1, 2025: Dividend Reset, Defense Contracts and What Analysts Expect Next

Lockheed Martin (LMT) Stock on December 1, 2025: Dividend Reset, Defense Contracts and What Analysts Expect Next

Lockheed Martin shares fell 3.2% to $443.09 in late trading December 1, coinciding with the stock’s ex-dividend date for a newly increased $3.45 quarterly payout. The company announced its 23rd consecutive annual dividend hike, raising the forward yield to about 3%. LMT shares are down 6.9% over the past month, underperforming the S&P 500 and the broader defense sector.
1 December 2025
Super Micro Computer (SMCI) Stock on December 1, 2025: AI Server Star Caught Between Growth and Margin Squeeze

Super Micro Computer (SMCI) Stock on December 1, 2025: AI Server Star Caught Between Growth and Margin Squeeze

Super Micro Computer (SMCI) closed December 1, 2025, at $33.40, down 1.3%, with over 11 million shares traded. The stock has fallen about 35% in a month after a revenue guidance cut and record-low Q1 gross margin of 9.3%. SMCI now trades at half its 52-week high but remains up roughly 1,000% over five years. Management cited delayed AI deals and ongoing strong demand.
Oklo (OKLO) Stock in December 2025: Siemens Deal, DOE Breakthrough and a Nuclear-AI Roller Coaster

Oklo (OKLO) Stock in December 2025: Siemens Deal, DOE Breakthrough and a Nuclear-AI Roller Coaster

Oklo Inc. (NYSE: OKLO) traded at $89.65 per share early afternoon December 1, 2025, with a market cap of $14.01 billion. The stock is up over 4x from its 52-week low but down nearly 54% from its October peak. Swiss National Bank more than doubled its stake, and Oklo announced a binding contract with Siemens Energy for its first commercial Aurora powerhouse. No revenue reported; trailing 12-month EPS is –$0.58.
ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

ServiceNow shares traded near $820 Monday, about 33% below January’s 52-week high and down 24% year-to-date, while the Nasdaq rose 20%. Third-quarter results beat expectations, with revenue up 22% to $3.41 billion and adjusted EPS at $4.82. The board has proposed a five-for-one stock split, with a shareholder vote set for December 5. Market cap stands at roughly $170 billion.
MongoDB (MDB) Stock on December 1, 2025: Earnings Preview, New CEO and Wall Street Forecasts

MongoDB (MDB) Stock on December 1, 2025: Earnings Preview, New CEO and Wall Street Forecasts

MongoDB reports fiscal Q3 results after markets close Monday, following a preannouncement that revenue and earnings will top prior guidance. Shares last traded at $333.61, valuing the company at $27 billion, after a recent pullback from near $385. CJ Desai took over as CEO on November 10, replacing Dev Ittycheria, who remains on the board.
Lululemon (LULU) Stock on December 1, 2025: Price, Latest News, Analyst Forecasts and 2026 Outlook After a 52% Sell-Off

Lululemon (LULU) Stock on December 1, 2025: Price, Latest News, Analyst Forecasts and 2026 Outlook After a 52% Sell-Off

Lululemon shares closed at about $184 on December 1, 2025, down 52% year-to-date and roughly 50% over three and five years. The company reported Q2 net revenue of $2.53 billion, up 7%, but U.S. sales fell 4% while international comps rose 15%. Fiscal 2025 guidance was cut, with expected EPS of $12.77–$12.97, down from $14.64 last year. Market cap stands near $22 billion.
1 December 2025
Deere & Company Stock Outlook December 1, 2025: Tariff Shock, Q4 Earnings and AI‑Powered Future for DE

Deere & Company Stock Outlook December 1, 2025: Tariff Shock, Q4 Earnings and AI‑Powered Future for DE

Deere & Company closed at about $472 per share on December 1, 2025, with a market cap in the mid-$120 billion range. Q4 revenue rose 11% to $12.39 billion, but net income fell 14% to $1.07 billion. Full-year net income dropped 29% to $5.03 billion. The company forecast 2026 net income of $4.0–$4.75 billion amid tariff pressures and a weak large-agriculture cycle.
Coca-Cola (KO) Stock on Ex‑Dividend Day: Price, Dividend Outlook, Fresh Forecasts and Key Risks (December 1, 2025)

Coca-Cola (KO) Stock on Ex‑Dividend Day: Price, Dividend Outlook, Fresh Forecasts and Key Risks (December 1, 2025)

Coca‑Cola shares traded around $72.10 midday December 1, down 1.3% as the stock went ex‑dividend but remained near record highs. The company’s market cap stands at about $310 billion, up 14% over the past year. The quarterly dividend is $0.51 per share, with a forward yield near 2.8%. Coca‑Cola’s forward P/E is about 22.7, above the industry average.
Booking Holdings (BKNG) Stock Outlook for December 2025: Q3 Beat, AI Deals, Buybacks and a 30% Upside Case

Booking Holdings (BKNG) Stock Outlook for December 2025: Q3 Beat, AI Deals, Buybacks and a 30% Upside Case

Booking Holdings shares traded just under $4,920 at midday on December 1, 2025, valuing the company at about $158 billion, near the low end of its 52-week range. The company announced a new integration with Spotnana, giving corporate travel clients direct access to Booking.com’s global inventory. Institutional investors control over 92% of the float. Booking’s quarterly dividend now stands at $9.60 per share.
Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Zeekr Group (NYSE: ZK) last traded at about $26.70 per ADS, with a market cap near $6.8 billion, as Geely’s $26.87 per ADS take-private offer dominates trading. November deliveries hit 63,902 vehicles, up 7.1% year-over-year. The company launched sales in Germany on December 1, 2025, while Q3 revenue reached $4.43 billion with a gross margin of 19.2%. Zeekr remains loss-making and financially strained.
Qualcomm (QCOM) Stock Outlook 2025–2026: AI Pivot, UK Lawsuit and What the Latest Earnings Mean for Investors

Qualcomm (QCOM) Stock Outlook 2025–2026: AI Pivot, UK Lawsuit and What the Latest Earnings Mean for Investors

Qualcomm shares traded near $167.80 on December 1, 2025, valuing the company at about $180 billion. Fiscal Q4 revenue rose 10% to roughly $11.3 billion, but a $5.7 billion tax charge led to a GAAP net loss of $3.1 billion. The stock remains about 18% below its 52-week high. Qualcomm repurchased 1.8 million shares in late November as part of a $15 billion buyback program.
1 December 2025
Carvana (CVNA) Stock on December 1, 2025: UBS Buy Rating, Wedbush Upgrade and Q3 Earnings Fuel a High‑Risk Rally

Carvana (CVNA) Stock on December 1, 2025: UBS Buy Rating, Wedbush Upgrade and Q3 Earnings Fuel a High‑Risk Rally

UBS initiated coverage of Carvana with a Buy rating and a $450 price target on December 1, 2025, following record Q3 results. Carvana shares traded at $375.01, up 0.14% late morning, with a market cap near $81.6 billion. The stock is up 84% year-to-date but faces valuation concerns and competition from Amazon Autos. Short interest remains around 8–9% of float.
Atmos Energy (ATO) in December 2025: Earnings Beat, 15% Dividend Hike and a Fresh Bullish Trend for Dividend Investors

Atmos Energy (ATO) in December 2025: Earnings Beat, 15% Dividend Hike and a Fresh Bullish Trend for Dividend Investors

Atmos Energy shares traded near $175 on December 1, 2025, close to a 52-week high, after the company raised its dividend nearly 15% and posted annual EPS of $7.46. Fiscal 2025 net income reached $1.2 billion on $3.6 billion in capital spending. Analysts remain divided as valuation sits above consensus targets despite robust fundamentals. Management projects further growth in fiscal 2026.
1 December 2025
Niger Uranium Shock: SOMAIR Mine, Orano Dispute and the New Global Nuclear Power Map

Niger Uranium Shock: SOMAIR Mine, Orano Dispute and the New Global Nuclear Power Map

On 1 December 2025, Niger moved about 1,050 tonnes of uranium from the expropriated SOMAIR mine, defying an international tribunal order and French nuclear firm Orano’s objections. Orano said it did not authorize the shipment and warned of safety risks. Niger’s junta declared its right to sell uranium on the open market, challenging France’s long-standing control of the sector.
1 December 2025
Shopify Cyber Monday Outage 2025: What’s Happening, How Bad It Is, and What Merchants Should Do Now

Shopify Cyber Monday Outage 2025: What’s Happening, How Bad It Is, and What Merchants Should Do Now

Shopify is experiencing a major outage on Cyber Monday 2025, with thousands of merchants worldwide unable to log in or access admin dashboards since around 9 a.m. ET. Storefronts and POS systems are also affected, and Shopify’s support channels remain slow or unreachable. The company has confirmed degraded performance but has not resolved the incident as of early afternoon. Consumer spending is projected to hit record highs during the disruption.
1 December 2025
SPY Stock Outlook Today: SPDR S&P 500 ETF Starts December 2025 in the Red as Santa Rally Hopes Meet Fed Jitters

SPY Stock Outlook Today: SPDR S&P 500 ETF Starts December 2025 in the Red as Santa Rally Hopes Meet Fed Jitters

SPDR S&P 500 ETF Trust (SPY) traded around $680.69 late Monday morning, down about 0.4% from Friday’s $683.39 close, mirroring a broader U.S. market pullback. SPY remains within a few dollars of its all-time high of $689.70, with year-to-date total return near 17%. Investors are watching for economic data and a speech from Fed Chair Jerome Powell later this month.
TKMS Stock on 1 December 2025: Price, Outlook and Key Risks After the Blockbuster Frankfurt Debut

TKMS Stock on 1 December 2025: Price, Outlook and Key Risks After the Blockbuster Frankfurt Debut

TKMS shares traded at €62–64 on 1 December 2025, down sharply from the €107 intraday peak at its 20 October Frankfurt debut but above the €60 listing price. Market capitalization stands at about €4.1–4.2 billion. Thyssenkrupp retains a 51% stake after spinning off the naval builder. TKMS reported €2.16 billion in trailing revenue and an €18.6 billion order backlog.
1 December 2025

Stock Market Today

  • Options Traders Reflect on Toughest Lessons Learned
    April 27, 2026, 3:59 PM EDT. Options traders discuss valuable insights gained from difficult experiences in the derivatives market. Trading options-contracts granting the right to buy or sell an asset at a set price-requires understanding complex risks. Many traders highlight the importance of discipline, managing losses, and resisting emotional decisions. These lessons often come after costly mistakes, underlining how quickly volatility and leverage can amplify losses. Industry voices stress education and strategy adjustments as key to survival and success in options trading.

Latest article

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

27 April 2026
Intellia Therapeutics reported its CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% versus placebo in a late-stage trial, with 62% of treated patients attack- and therapy-free over six months. The company has started a rolling U.S. approval application. No serious adverse events were reported. Intellia shares fell 0.9% to $13.51 after initial gains.
U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

27 April 2026
U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

27 April 2026
Veradermics shares rose 40% Monday after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial of 519 men. Patients taking the drug saw average hair count increases of 30.3 to 33.0 hairs per square centimeter over six months, compared to 7.3 for placebo. No treatment-related serious or heart-related adverse events were reported.
Go toTop